Elder Pharmaceuticals in association with Spain-based drug firm Ferrer has unveiled -- Zalain -- a medicine used to treat fungal skin infections, in India. The company has launched the same to strengthen its anti-infectives division which stood at about Rs 113.61 crore in FY 2012
The company, to strengthen position in the segment in domestic market, has also lined-up five more launches of nutraceutical products in India in partnerships with international firms in the coming six months.
At present, the company markets various nutraceutical products in the country, including calcium supplement -- Shelcal. Its product portfolio comprises licensed as well as own brands.
Elder Pharmaceuticals posted 15.46% fall in its consolidated net profit at Rs 14.60 crore for the quarter ended March 31, 2012 as compared to Rs 17.27 crore in the corresponding period of previous fiscal. The fall is mainly on account of reduction in material costs.
